Ms. Alice Porazzi | Biomedical Omics | Best Researcher Award

European Instiute of Oncology | Italy

Alice Porazzi is a dedicated biomedical researcher specializing in omics sciences and cancer biology. With a strong academic foundation in biotechnology and biomedical omics, she has cultivated expertise in genomics, radiomics, and bioinformatics. Currently serving as a pre-doctoral fellow at the European Institute of Oncology in Milan, she focuses on uncovering molecular mechanisms driving pancreatic ductal adenocarcinoma progression. Her previous research includes significant contributions to genomic analyses in lung cancer detection and sustainability in radiotherapy, emphasizing the integration of computational biology with medical applications. Alice is recognized for her exceptional academic achievements, consistently graduating with top honors, and for her interdisciplinary approach that bridges laboratory science and clinical research. She has presented and published her work in leading scientific journals and conferences, demonstrating a commitment to advancing cancer research. Known for her precision, resilience, and team-oriented approach, Alice’s career reflects a blend of technical excellence and passion for translational medicine.

Profile

Scopus

Education 

Alice Porazzi holds a Master’s degree in Biomedical Omics from Università degli Studi di Milano, where she graduated with top distinction. Her studies provided her with in-depth knowledge of multiple omics disciplines, including genomics, epigenomics, proteomics, metabolomics, and radiomics, along with hands-on training in data analysis and experimental design. She developed strong computational and laboratory skills, integrating bioinformatics approaches with advanced imaging and diagnostic techniques to support translational research. Alice also earned a Bachelor’s degree in Biotechnology, where she specialized in pharmaceutical biotechnology, gaining expertise in drug development, molecular biology, and biotechnological product analysis. Her academic journey reflects a consistent pursuit of excellence, with both degrees awarded summa cum laude, highlighting her outstanding academic performance. Additionally, she completed a rigorous secondary education in scientific studies, establishing a strong foundation in mathematics, chemistry, and biology. Her multidisciplinary training has equipped her to tackle complex biomedical challenges with a systems-level perspective and analytical precision.

Experience 

Alice Porazzi has developed extensive research experience through multiple roles in prestigious institutions. She is currently a pre-doctoral fellow at the European Institute of Oncology, where she investigates cellular plasticity and lineage fidelity loss in pancreatic cancer using harmonized transcriptomic resources. Prior to this, she worked at the Center for Omics Sciences at IRCCS Ospedale San Raffaele, contributing to projects on circulating biomarkers and cfDNA mutations for lung cancer detection. She also served as a research fellow at Università degli Studi di Milano, focusing on sustainable radiotherapy approaches in oncology. Her earlier internships explored radiomics-based imaging analysis and the anti-tumor properties of bioactive compounds in prostate cancer cells. Across these roles, Alice has developed expertise in next-generation sequencing, computational biology, and imaging-based biomarker discovery. Her career demonstrates a commitment to bridging laboratory science with clinical applications, supported by active involvement in academic collaborations, conference presentations, and scientific publications in high-impact journals.

Awards and Honors

Alice Porazzi has been consistently recognized for her academic excellence and scientific contributions. During her Master’s studies, she received the prestigious Fondazione Dompé Scholarship, awarded to top-performing students in recognition of outstanding merit and research potential. Her exceptional academic achievements include graduating summa cum laude in both her Bachelor’s and Master’s programs, highlighting her consistent pursuit of excellence. Alice’s work has been featured in high-impact journals and presented at leading international conferences, such as ESTRO and AIRO, where she delivered multiple poster presentations on radiomics, sustainable oncology practices, and biomarker development. Her research on cancer genomics and radiotherapy innovation has contributed to ongoing advancements in oncology. These achievements underscore her reputation as a promising early-career scientist. Beyond formal recognition, she has been commended for her diligence, analytical rigor, and leadership in collaborative projects, positioning her as a rising talent in biomedical research with a growing influence in translational cancer studies.

Research Focus 

Alice Porazzi’s research focuses on leveraging multi-omics technologies, computational biology, and radiomics to address complex challenges in oncology. Her current work explores the molecular mechanisms underlying pancreatic ductal adenocarcinoma progression, with a focus on transcriptomic profiling to better understand cellular plasticity and resistance pathways. She has contributed extensively to biomarker discovery in lung cancer, analyzing circulating tumor DNA to improve early detection and diagnostic precision. Alice is also deeply engaged in studying sustainable oncology, assessing the environmental footprint of radiotherapy practices and integrating radiogenomic data for personalized treatment strategies. Her interdisciplinary expertise combines genomics, imaging analytics, and computational modeling to bridge the gap between bench research and clinical applications. Passionate about translational medicine, she aims to develop innovative, patient-centered approaches that enhance cancer diagnosis, prognosis, and therapy optimization. Her work reflects a commitment to scientific excellence and collaboration, driving advancements at the intersection of bioinformatics, molecular biology, and oncology.

Publications

Title: CT-Based Radiomics Enhance Respiratory Function Analysis for Lung SBRT
Year: 2025

Title: Green Radiotherapy: a focus on hypofractionation in prostate cancer. Is radiotherapy as green as we would like? A preliminary analysis on 100 patients
Year: 2025

Title: Circulating biomarkers to improve non-small-cell lung cancer early detection
Year: 2025

Title: Loss of Oncogene-Addiction as Mechanism of Resistance to Osimertinib
Year: 2025

Title: Understanding the role of nerves in head and neck cancers – a review
Year: 2024

Conclusion

Alice Porazzi demonstrates exceptional promise as a biomedical researcher, with an impressive record of academic excellence, impactful publications, and interdisciplinary expertise. Her innovative work in cancer research and omics-based medicine reflects strong potential for long-term contributions to science and healthcare. She is highly deserving of consideration for the Best Researcher Award.